Abstract
Odontogenic infections are commonly managed by oral and maxillofacial surgeons and generally require antimicrobial therapy with surgical management. Penicillins are a potent antibiotic in managing these infections, but 10% of the population has a penicillin allergic label (PAL). This label has limited their use and resulted in increased utilization of health care resources, antibiotic resistance, and complications associated with inappropriate use of antibiotics. Additionally, severe odontogenic infection patients are ascribed to many tests during the perioperative period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
